Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (191-200 of 531) with videos related to

Pageof 54
Sort By:
Pharmacotherapy|June 14, 2020
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysisPramodini B Kale-Pradhan, Christopher Giuliano, Annelise Jongekrijg, et al.
Birth Defects Original Article Series|January 1, 1975
Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy- a new hereditary syndromeS G Lazoff, J J Rybak, B R Parker, et al.
Therapeutic Drug Monitoring|January 1, 1988
Comparison of serum sampling methods for determining vancomycin dosage regimensL M Albrecht, M J Rybak, S C Boike, et al.
Pharmacotherapy|May 16, 2000
Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal functionM M Neuhauser, P S McKinnon, E Hershberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targetsRavina Kullar, Susan L Davis, Donald P Levine, et al.
International Journal of Antimicrobial Agents|November 11, 2009
Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureusVanthida Huang, Chrissy M Cheung, Glenn W Kaatz, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 26, 2013
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?Jessica K Ortwine, Brian J Werth, George Sakoulas, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2008
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic modelWarren E Rose, Glenn W Kaatz, George Sakoulas, et al.
The Journal of Infectious Diseases|June 26, 2001
Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissueD J Bidanset, R J Rybak, C B Hartline, et al.
Pageof 54

Showing results (191-200 of 531) with videos related to

Sort By:
Pageof 54
Pharmacotherapy|June 14, 2020
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysisPramodini B Kale-Pradhan, Christopher Giuliano, Annelise Jongekrijg, et al.
Birth Defects Original Article Series|January 1, 1975
Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy- a new hereditary syndromeS G Lazoff, J J Rybak, B R Parker, et al.
Therapeutic Drug Monitoring|January 1, 1988
Comparison of serum sampling methods for determining vancomycin dosage regimensL M Albrecht, M J Rybak, S C Boike, et al.
Pharmacotherapy|May 16, 2000
Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal functionM M Neuhauser, P S McKinnon, E Hershberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targetsRavina Kullar, Susan L Davis, Donald P Levine, et al.
International Journal of Antimicrobial Agents|November 11, 2009
Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureusVanthida Huang, Chrissy M Cheung, Glenn W Kaatz, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 26, 2013
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?Jessica K Ortwine, Brian J Werth, George Sakoulas, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2008
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic modelWarren E Rose, Glenn W Kaatz, George Sakoulas, et al.
The Journal of Infectious Diseases|June 26, 2001
Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissueD J Bidanset, R J Rybak, C B Hartline, et al.
Pageof 54